Neumora Therapeutics, Inc. (NMRA)
2.555
-0.08
(-3.22%)
USD |
NASDAQ |
Mar 19, 12:20
Neumora Therapeutics EPS Diluted (Quarterly) : -0.3507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Protalix Biotherapeutics, Inc. | -0.0684 |
| Nautilus Biotechnology, Inc. | -0.109 |
| Ventyx Biosciences, Inc. (DELISTED) | -0.3202 |
| ProKidney Corp. | -0.122 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.76M |
| Total Expenses (Quarterly) | 56.76M |
| Enterprise Value | 289.68M |
| Earnings Yield | -57.27% |
| Normalized Earnings Yield | -56.43 |